InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3050% below fair value
$0.69+0.04 (+5.48%)
Close on Nov 18, 2026Market cap $31.87MP/E –Yield –
InspireMD free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
InspireMD's free cash flow for the twelve months ending Jun 30, 2026 was -$42.46M. For fiscal 2025 it was -$36.77M. The highest annual figure on record is -$1.58M in fiscal 2009.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.77M | – |
| FY2024 | Dec 31, 2024 | -$23.27M | – |
| FY2023 | Dec 31, 2023 | -$16.76M | – |
| FY2022 | Dec 31, 2022 | -$16.02M | – |
| FY2021 | Dec 31, 2021 | -$13.55M | – |
| FY2020 | Dec 31, 2020 | -$9.17M | – |
| FY2019 | Dec 31, 2019 | -$10.09M | – |
| FY2018 | Dec 31, 2018 | -$7.67M | – |
| FY2017 | Dec 31, 2017 | -$8.39M | – |
| FY2016 | Dec 31, 2016 | -$7.54M | – |
| FY2015 | Dec 31, 2015 | -$11.61M | – |
| FY2013 | Jun 30, 2013 | -$10.50M | – |
| FY2010 | Dec 31, 2010 | -$2.79M | – |
| FY2009 | Dec 31, 2009 | -$1.58M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.23M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.53M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.74M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.96M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.12M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.26M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.39M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.14M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.37M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.86M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.33M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.22M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.17M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.01M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.30M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.58M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.67M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.26M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.93M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.00M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.55M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.83M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.22M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.78M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.80M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.08M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.60M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.91M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.92M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.96M | – |
See a number that looks wrong?